Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.660
-0.030 (-1.78%)
Nov 6, 2025, 4:00 PM EST - Market closed

Cognition Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
146295961139-
Upgrade
Market Cap Growth
673.62%-50.97%-2.39%-56.29%--
Upgrade
Enterprise Value
10782715216-
Upgrade
Last Close Price
1.660.701.852.106.32-
Upgrade
PB Ratio
4.011.552.431.512.72-
Upgrade
P/TBV Ratio
4.011.552.431.512.72-
Upgrade
Debt / Equity Ratio
0.010.040.050.04--1.00
Upgrade
Quick Ratio
6.202.493.075.807.251.95
Upgrade
Current Ratio
6.452.653.376.117.502.13
Upgrade
Return on Equity (ROE)
-109.73%-157.19%-79.69%-46.76%-60.93%-
Upgrade
Return on Assets (ROA)
-78.99%-103.15%-74.08%-49.69%-53.95%-149.26%
Upgrade
Return on Capital (ROIC)
-107.88%-148.99%-94.02%-58.54%-69.67%-1506.84%
Upgrade
Earnings Yield
-19.11%-116.59%-43.40%-35.15%-8.41%-
Upgrade
FCF Yield
-20.17%-97.74%-27.20%-30.72%-2.63%-
Upgrade
Buyback Yield / Dilution
-70.13%-32.31%-27.03%-355.42%-921.60%-8.18%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q